di Editorial Team Digital Health Global, 10/01/2019
At CES 2019, the digital therapeutic company’s CEO and cofounder described work on an independent prescription, procurement and support platform specific to digital medicines
Digital therapeutics are a nascent corner of the healthcare technology industry. With few precedents available outside of novel drugs or medical devices, it would make sense that Pear Therapeutics, Proteus and other digital therapeutics companies furthest along the regulatory pipeline align themselves with industry partners well versed in selling and supporting a medical product.
As such, it came as a bit of a surprise when Akili Interactive Labs CEO and cofounder Eddie Martucci casually mentioned that his company would be bucking the trend of its contemporaries by building its own distribution platform for the video game-based therapeutic, as opposed to relying on relationships and sales channels of an established pharmaceutical company.